CoraLite® Plus 405 Anti-Human CD16 (3G8)
CD16 Monoclonal Antibody for FC
Host / Isotype
Mouse / Mouse IgG1, k
Reactivity
Human
Applications
FC
Conjugate
CoraLite® Plus 405 Fluorescent Dye
CloneNo.
3G8
Cat no : CL405-65090
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL405-65090 targets CD16 in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / Mouse IgG1, k |
Class | Monoclonal |
Type | Antibody |
Immunogen | N/A |
Full Name | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
Calculated Molecular Weight | 254 aa, 29 kDa |
GenBank Accession Number | BC017865 |
Gene Symbol | CD16a |
Gene ID (NCBI) | 2214 |
Conjugate | CoraLite® Plus 405 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 399 nm / 422 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD16 is a 50-70-kDa low affinity Fc receptor found on the surface of natural killer cells, neutrophil polymorphonuclear leukocytes, monocytes and macrophages. CD16 mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis. CD16 has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b), encoded by two nearly identical genes, FCGR3A and the FCGR3B. Clone 3G8 recognizes both the CD16a and CD16b (PMID: 7592758).
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 405 CD16 antibody CL405-65090 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |